Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts
Source: SeekingAlpha
2026-01-28 12:05:37 ET
More on Shattuck Labs
- Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot
- Seeking Alpha’s Quant Rating on Shattuck Labs
- Historical earnings data for Shattuck Labs
- Financial information for Shattuck Labs
Read the full article on Seeking Alpha
For further details see:
Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts
Shattuck Labs Inc.
NASDAQ: STTK
STTK Trading
1.77% G/L:
$6.025 Last:
183,513 Volume:
$5.98 Open:
STTK Latest News
March 05, 2026 06:15:00 am
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
February 25, 2026 08:00:00 am
Shattuck Labs Announces Participation in Upcoming March Investor Conferences
February 06, 2026 08:30:00 am
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
STTK Stock Data
$256,916,163
29,298,567
2.43%
13
N/A
Biotechnology & Life Sciences
Healthcare
US
Austin
